Sign up
Healthed-White-on-Blue

Beclometasone/ formoterol/ glycopyrronium pMDI for maintenance treatment of moderate to severe COPD

Description

In this Product Explainer, Dr Philip Lee explains the role of beclomethasone/ formoterol/ glycopyrronium pressurised metered dose inhalers (pMDIs) for maintenance treatment of adults with moderate to severe COPD who are not adequately treated by ICS/LABA or LABA/LAMA (7 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Emily Nash

Dr Emily Nash

Abnormal Liver Function Test

Prof Andrew Sindone AM

Prof Andrew Sindone AM

Heart Failure Exacerbation – Important Management Steps After Hospital Discharge

Prof Michelle Giles OAM

Prof Michelle Giles OAM

Practical Strategies to Address Falling Vaccination Rates in Mums and Bubs

Prof Richard Harvey

Prof Richard Harvey

Recurrent Nasal Polyps Management – When to Refer

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

31 March 2026
Register Now
Dr Philip Lee

expert

Dr Philip Lee

Respiratory and Sleep Physician; Consultant, Respiratory and Sleep Medicine, St George and Northern Beaches Hospitals

Date published: 14 August 2024

Discover

Healthed

CPD platform